WebChromosomal instability not only has a negative effect on survival in triple-negative breast cancer, but also on the well treatable subgroup of luminal A tumors. This suggests a general mechanism independent of subtypes. Increased chromosomal instability (CIN) in triple … WebApr 2, 2024 · Although Chk1 is a promising therapeutic target in p53-deficient cancers, we found that Ras–MEK signaling engages Chk1 in a subset of osteosarcoma, ovarian, and breast cancer cells to enable their survival upon DNA damage, irrespective of …
Checkpoint kinase1 (CHK1) is an important biomarker in breast …
WebApr 5, 2024 · CASC-578 is a highly selective, picomolar inhibitor of Chk1 that is active as a single agent and in combination with chemotherapeutic agents in a variety of solid tumor … WebMay 13, 2024 · Therefore, CHK1 inhibition combined with gemcitabine may be a potential treatment for bladder cancer. Checkpoint kinases (CHKs) are involved in the DNA … log in life 360
CHK1 frameshift mutations in genetically unstable colorectal …
WebLung cancer is the leading cause of cancer-related death. In particular, non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. ... Mechanistically, lutein exerted antitumorigenic effects by inducing DNA damage and subsequently activating the ATR/Chk1/p53 signaling pathway in A549 cells. In vivo, lutein ... WebAug 1, 2001 · A shorter somatic isoform of CHK1 mRNA, as well as a rare polymorphism or possible germ-line mutation in a patient with small cell lung cancer, have also been reported .These findings suggest that the loss of CHK1 function may be important in tumor formation in different cancer types. According to our data, CHK1 is not a major gene for LFS. WebMay 1, 2003 · In this review, we highlight the roles of mammalian kinases Chk1 and Chk2 (the latter also known as Cds1 or CHEK2), two critical messengers of the genome … login lifereader